Rare Disease Senior Medical Science Liaison- South Central

About the role

Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines in four disease areas: bone and mineral; intractable hematologic; hematology oncology; and rare disease. Headquartered in Japan with North American headquarters in Princeton, NJ and offices in California, Massachusetts, and Ontario, the Senior Medical Science Liaison (MSL) is a field-based member of the Medical Affairs organization responsible for serving as a scientific and clinical expert for the company's therapeutic area(s) and products. This position covers the Dallas, TX, Houston, TX, and Phoenix, AZ territories, along with surrounding markets throughout the region; candidates must live within the territory.

Responsibilities

• Independently identify, establish, and advance strategic scientific relationships with international, national, regional, and local key opinion leaders (KOLs), healthcare professionals (HCPs), investigators, and other external stakeholders.
• Educate healthcare professionals and other appropriate stakeholders on Kyowa Kirin’s scientific data, disease states, therapeutic landscape, emerging clinical evidence, and product portfolio.
• Deliver accurate, transparent, fair-balanced, evidence-based, and compliant scientific and clinical information in a timely and customer-focused manner, including responses to unsolicited medical information requests.
• Serve as a regional medical and scientific resource by identifying external stakeholder needs and connecting them with appropriate Kyowa Kirin capabilities, resources, initiatives, and scientific collaborations.
• Gather, critically analyze, synthesize, and communicate actionable medical insights, unmet medical needs, treatment trends, and competitive intelligence, identifying strategic implications and recommended actions for Medical Affairs and cross-functional stakeholders.
• Develop and deliver scientific presentations, educational programs, clinical resources, and other materials in response to identified stakeholder needs and appropriate requests.
• Independently liaise between investigators and Kyowa Kirin regarding unsolicited investigator-initiated study proposals and ongoing investigator-initiated studies (IIS), in accordance with company policies and regulatory requirements.